Education
About Us
Working with TipRanks
Follow Us
American Oncology Network (AONC)
OTHER OTC:AONC
Total Valuation
American Oncology Network has a market cap or net worth of $376.23M. The enterprise value is $370.11M.
Market Cap$376.23M
Enterprise Value$370.11M
Share Statistics
American Oncology Network has 32,129,753 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding32,129,753
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
American Oncology Network’s return on equity (ROE) is -0.21 and return on invested capital (ROIC) is -7.23%.
Return on Equity (ROE)-0.21
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)-7.23%
Return on Capital Employed (ROCE)-0.07
Revenue Per Employee919.27K
Profits Per Employee-14.08K
Employee Count1,914
Asset Turnover3.74
Inventory Turnover27.04
Valuation Ratios
The current PE Ratio of American Oncology Network is ―. American Oncology Network’s PEG ratio is 0.35.
PE Ratio―
PS Ratio0.04
PB Ratio3.70
Price to Fair Value3.70
Price to FCF-2.68
Price to Operating Cash Flow1.58
PEG Ratio0.35
Income Statement
In the last 12 months, American Oncology Network had revenue of 1.76B and earned -3.97M in profits. Earnings per share was -0.69.
Revenue1.76B
Gross Profit117.85M
Operating Income-17.43M
Pretax Income-24.46M
Net Income-3.97M
EBITDA1.81M
Earnings Per Share (EPS)-0.69
Cash Flow
In the last 12 months, operating cash flow was 28.98M and capital expenditures -16.91M, giving a free cash flow of 12.07M billion.
Operating Cash Flow28.98M
Free Cash Flow12.07M
Free Cash Flow per Share0.38
Dividends & Yields
American Oncology Network pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.17
52-Week Price Change170.48%
50-Day Moving Average10.36
200-Day Moving Average8.10
Relative Strength Index (RSI)36.16
Average Volume (3m)2.55K
Important Dates
American Oncology Network upcoming earnings date is Nov 18, 2025, Before Open (Confirmed).
Last Earnings DateMar 27, 2025
Next Earnings DateNov 18, 2025
Ex-Dividend Date―
Financial Position
American Oncology Network as a current ratio of 1.53, with Debt / Equity ratio of 785.08%
Current Ratio1.53
Quick Ratio1.25
Debt to Market Cap1.31
Net Debt to EBITDA46.57
Interest Coverage Ratio-2.47
Taxes
In the past 12 months, American Oncology Network has paid 2.50M in taxes.
Income Tax2.50M
Effective Tax Rate-0.10
Enterprise Valuation
American Oncology Network EV to EBITDA ratio is 84.81, with an EV/FCF ratio of -5.94.
EV to Sales0.09
EV to EBITDA84.81
EV to Free Cash Flow-5.94
EV to Operating Cash Flow-31.14
Balance Sheet
American Oncology Network has $72.64M in cash and marketable securities with $147.37M in debt, giving a net cash position of -$74.73M billion.
Cash & Marketable Securities$72.64M
Total Debt$147.37M
Net Cash-$74.73M
Net Cash Per Share-$2.33
Tangible Book Value Per Share$6.90
Margins
Gross margin is 6.70%, with operating margin of -0.99%, and net profit margin of -0.23%.
Gross Margin6.70%
Operating Margin-0.99%
Pretax Margin-1.39%
Net Profit Margin-0.23%
EBITDA Margin0.10%
EBIT Margin-1.00%
Analyst Forecast
The average price target for American Oncology Network is $9.00, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
Price Target$9.00
Price Target Upside5.63% Upside
Analyst ConsensusModerate Sell
Analyst Count0
Revenue Growth Forecast166.39%
EPS Growth Forecast15.50%